Ep135: John Maraganore on Developing a New Class of Medicines
Ep135: John Maraganore on Developing a New Class of Medicines  
Podcast: The Long Run with Luke Timmerman
Published On: Mon May 08 2023
Description: John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.